Glutamine is administered orally at a rate of about 4.5 g/m.sup.2 per day to treat oropharyngeal mucositis. This is administered to patients that experience or may develop oropharyngeal mucositis, especially those caused by chemotherapy or radiotherapy.

 
Web www.patentalert.com

> Systems and methods for conducting a peer review process and evaluating the originality of documents

~ 00322